Over the past six months, Moderna’s shares (currently trading at $25.79) have posted a disappointing 19.2% loss, well below ...

Moderna’s second quarter results were met with a negative market reaction, as investors focused on both a sharp decline in ...

Scientists used IBM's R2 Heron quantum processor to predict the secondary protein structure of a 60-nucleotide-long mRNA ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the cancer spreads to the peritoneum or the lining of the abdominal cavity, ...

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

The U.S. health secretary ordered an end to new mRNA development efforts just after UTMB published new research showing its ...

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...